A novel study by researchers at the Icahn School of Medicine at Mount Sinai addresses a critical yet under-explored question in cancer research: Why is aging the biggest risk factor for cancer? The study reveals how an aging immune system spurs tumor growth, offering new insights into cancer prevention and treatment, especially for older adults.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a noninvasive technique that could dramatically improve the way doctors monitor intracranial hypertension, a condition where increased pressure in the brain can lead to severe outcomes like strokes and hemorrhages.
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.
Investigating a new frontier in understanding diseases like obesity and type 2 diabetes.
Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy.
Mount Sinai is celebrating its 12th year as the official hospital and medical services provider of the US Open Tennis Championships, which begins with Fan Week August 19-25 and continues with the Main Draw August 26-September 8. It is also Mount Sinai’s 10th year in this capacity for the U.S. Teams for the Billie Jean King Cup and Davis Cup events.
The Icahn School of Medicine at Mount Sinai, a top ranked medical school in the U.S., known for its strong culture of innovation and scholarship, is launching a re-envisioned curriculum for MD students.
A new study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV, and offers new insight on transmission.
The American Society of Retina Specialists is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with the prestigious Founders Award for 2024.
The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence by U.S. News & World Report®, marking the ninth straight year the hospital has been listed among the top 20 in the country on the publication’s “Honor Roll.”
Ramaiah Memorial Hospital (RMH), one of India's leading multi-super-specialty quaternary care hospitals based at Bengaluru, Karnataka, has signed an exclusive agreement with the New York-based Mount Sinai Health System today, marking the beginning of a transformative partnership that aims at advancing healthcare services through collaborations in clinical excellence, quality of care, research, innovation and technology.
First-of-its-kind clinical trial with specific JAK inhibition will investigate the best treatment for inflammatory skin conditions in these patients
Research published in Science Translational Medicine advances therapies to regenerate beta cells as a potential new treatment for diabetes
The Mount Sinai Health System announced it had been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.
Mount Sinai study suggests adhering to FDA-regulated expiration dates could prevent this
Mount Sinai-led study demonstrates significant safety outcomes and could lead to more frequent use of this new technology
$5 million grant from the Agency for Healthcare Research and Quality will enhance long COVID care for underserved minority groups, community outreach, and research
In a study published June 26 in Nature Communications, researchers from the Icahn School of Medicine at Mount Sinai reported finding major differences between postmortem and living prefrontal cortex brain tissues as they relate to one of the most abundant RNA modifications in the brain, known as adenosine-to-inosine (A-to-I) editing.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right